Search

Your search keyword '"O.D. Ostroumova Ostroumova"' showing total 55 results

Search Constraints

Start Over You searched for: "O.D. Ostroumova Ostroumova" Remove constraint "O.D. Ostroumova Ostroumova"
55 results on '"O.D. Ostroumova Ostroumova"'

Search Results

1. Medication errors as risk factor for drug-induced diseases

2. Risk factors of drug-induced diseases. Part 1. Classification, non-modified risk factors

4. NSAID-induced liver damage with cholestasis

5. Choosing an antianginal therapy strategy in patients with stable coronary artery disease in real clinical practice: the advantages of trimetazidine

6. What do we Mean by 'Ideal' Blood Pressure Control?

8. Inflammaging: inflammation and oxidative stress as a cause of aging and cognitive decline

9. Aspects of practical application of ‘STOPP/START’ criteria in elderly patients with atrial fibrillation and chronic kidney disease in therapeutic department of multi‑speciality hospital

10. Possibilities of using fosinopril in treatment of patients with chronic kidney disease in combination with cardiovascular diseases and diabetes mellitus

11. Drug-induced (medication-induced) depression in neurology practice

12. Drug-induced atrial fibrillation/flutter associated with drugs affecting the central nervous system

13. The relationship of cardiovascular disease with increased intestinal permeability: results from scientific and controlled clinical trials. Focus on the potential of rebamipide

14. Advanced Age as a Risk Factor of Drug-Induced Diseases

15. Drug-induced autoimmune hepatitis

16. Optimization of Pharmacotherapy Within the Framework of a Patient-oriented Approach in the Treatment of Hypertension in Multimorbidity Patients (Clinical Case and Literature Review)

17. Electrolyte deficiency after the novel coronavirus infection and post-COVID asthenia

18. Drug-induced acute interstitial nephritis

20. Drug-induced liver injury with cholestasis. Part 1: focus on drugs for the treatment of cardiovascular diseases and hypoglycemic drugs

22. Potential of nicergoline in polymorbidity and cognitive impairment (clinical case)

23. Medications associated with development of drug-induced depression

24. Mildronate. Chronic fatigue syndrome

25. Drug-induced diseases: approaches to diagnosis, correction and prevention. Pharmacovigilance

26. Choosing optimal cerebroprotection strategy for polymorbid stroke patient

27. Drug-induced diseases: epidemiology and urgency of the problem

28. Individual drugs associated with overweight inducing

30. Drug-induced hypothyroidism

34. Levocarnitine for the Treatment of Polymorbid Patients

36. Drug-induced atrial fibrillation associated with admission of cardiovascular medications

37. Drug-induced acute tubular necrosis

38. Drug-induced hyperthyroidism

39. Hypoglycemic drugs and drug-induced heart failure

40. Drug-induced pirouette-type tachycardia

41. Drug-induced nightmares

43. Stroke prevention in patients with atrial fibrillation and comorbidities

44. Asthma and cardiovascular disease

45. The new coronavirus infection followed by damage to the heart, lungs, skin and kidneys

46. Angiotensin-converting enzyme inhibitors – the risk of dementia and possibilities of improving cognitive functions: the unique characteristics of perindopril

49. The association of arterial hypertension and ischemic heart disease is the main problem in modern cardiology practice

50. Arterial hypertension and cognitive function

Catalog

Books, media, physical & digital resources